| Date | Title | Description | Source |
| 16.04.2024 | Counterfeit Botox blamed in 9-state outbreak of botulism-lik... | Biden administration investigating counterfeit botox injections in Florida, eight other states
Biden... | cbsnews.co... |
| 12.04.2024 | Dr. Donath Recognized on Cincinnati's Top Doctors List in Ci... | Dr. Alexander S. Donath, a renowned facial plastic surgeon in Cincinnati, was named a Cincinnati Top... | prweb.com/... |
| 21.03.2024 | More Middle-Aged and Older Men Are Seeking Male Breast Reduc... | The mean age of men seeking gynecomastia surgery at Amaris B. Clinic Singapore was 33. However, rece... | en.prnasia... |
| 13.03.2024 | Anxiety Disorder Treatment Market Size and Share Analysis, T... | Anxiety Disorder Treatment Market
Anxiety Disorder Treatment Market to Reach $15.89 Billion by 2030,... | einpresswi... |
| 12.03.2024 | Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 ... | - | globenewsw... |
| 12.03.2024 | UDCA Market Insights and Forecast to 2032: Mechanism of Acti... | - | globenewsw... |
| 09.03.2024 | CVS Pharmacy to Settle for $10 Million for Alaska Opioid Cri... | March 8, 2024
(Anchorage, AK) – The State of Alaska filed a complaint and consent judgment Thursda... | einpresswi... |
| 05.03.2024 | Health | The new beauty regimen: Lose weight with Ozempic, t... | Andrea Chang | Los Angeles Times (TNS)
LOS ANGELES — Jeniffer Brown wanted the Ozempic body. She jus... | dailycamer... |
| 04.03.2024 | Biopharmaceutical Innovations Lead the Way in Migraine Drugs... | Migraine is a clinical condition associated with painful headaches and other symptoms such as nausea... | einpresswi... |
| 21.01.2023 | Paxton Announces that Texas Has Joined $2.37 Billion Sett... | Attorney General Paxton announced that Texas is joining a $2.37 billion settlement with opioid manuf... | einpresswi... |
| 29.07.2022 | July 29, 2022 - Attorney General Miyares Announces $2.37 Bil... | Commonwealth of Virginia
Office of the Attorney General
Jason S. Miyares
Attorney General
202 North ... | einpresswi... |
| 29.07.2022 | Attorney General Bonta Announces $2.37 Billion Nationwide Se... | If finalized, the Allergan settlement, together with the Teva settlement announced earlier this week... | einpresswi... |
| 10.01.2022 | Ironwood Pharmaceuticals : Provides Update on FY 2021 Financ... | Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financi... | marketscre... |
| 04.11.2021 | Ironwood Pharmaceuticals Reports Third Quarter 2021 Results ... | Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Updat... | marketscre... |
| 17.03.2020 | Generic ‘identity’ gets lost when companies juggle both gene... | We think we know generic drug companies. They challenge patents held by brand firms. They litigate v... | statnews.c... |
| 25.06.2019 | AbbVie to Acquire Allergan for Approx. $63 Billion | Biopharma giant AbbVie Inc. (NYSE: ABBV) is to acquire Allergan plc (NYSE: AGN), a Dublin, Ireland-b... | finsmes.co... |
| 28.05.2019 | Mallinckrodt updates spin-off plans; FDA expands Vraylar... | → UK-based biopharmaceutical company Mallinckrodt $MNK — the maker of the controversial ... | endpts.com... |
| 17.05.2019 | Allergan wins a novel case over false ads by a compounder, b... | In a closely watched case, Allergan (AGN) won a lawsuit in which it used a novel legal theory to blu... | statnews.c... |
| 10.03.2019 | Clinical trials of Allergan’s antidepressant rapastinel fail... | The three studies – RAP-MD-01, -02 and -03 – measured change over a three-week period in baseline me... | medcitynew... |
| 07.08.2018 | Allergan picks up option for Editas' rare eye disease ... | → Allergan has stepped in to pick up its development option on Editas‘ experimental EDI... | endpts.com... |
| 24.07.2018 | A new treatment for a condition that can feel like tiny peop... | Reuters
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids... | businessin... |
| 15.06.2018 | Aimmune signs Jayson Dallas on to succeed retiring CEO;... | → Ex-Ultragenyx commercial chief Jayson Dallas is taking the helm at Aimmune Therapeutics $... | endpts.com... |
| 14.06.2018 | Sanofi sells manufacturing site to Recipharm; Aptose ... | → Sanofi is selling off its contract respiratory drug manufacturing site in the UK to Rec... | endpts.com... |
| 08.06.2018 | A handful of Allergan's top shareholders want to bring back ... | REUTERS/Shannon Stapleton
Former Allergan CEO David Pyott.
Advertisement
A handful of large Allergan... | businessin... |
| 27.04.2018 | Eyeing blockbuster migraine market, Allergan unloads ... | Allergan $AGN rolled out its second wave of positive Phase III data for its oral migraine dru... | endpts.com... |
| 20.04.2018 | 'Losing direction': Allergan investors are unhappy after a w... | Reuters
Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock... | businessin... |
| 03.01.2018 | Two biotech startups receive milestone payments | | startuptic... |
| 13.11.2017 | Alnylam's patisiran grabs EMA accelerated review; CR... | → Promising Phase III data on patisiran have proven quite productive for Alnylam, which anno... | endpts.com... |
| 11.10.2017 | Eye disease entrepreneurs raise $16M for Azura Ophthalmics | The founders of Azura have cut their teeth in the eye treatment sector. Dr. Yair Alster, founder and... | medcitynew... |
| 10.10.2017 | 'That should be illegal': Lawmakers are taking aim at pharma... | Reuters
Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock... | businessin... |
| 09.09.2017 | Allergan CEO gambles a multibillion-dollar franchise ... | Bioregnum — The view from Endpoints News
Allergan CEO Brent Saunders scored some heavyweight k... | endpts.com... |
| 14.03.2017 | Allergan antes up $90M in a landmark CRISPR/Cas9 collab... | Katrine Bosley, Editas. Credit: Jon Chomitz
Allergan is jumping into the CRISPR business.
T... | endpts.com... |
| 06.03.2017 | Allergan scores an FDA OK for a new drug targeting night... | Allergan has scored a new drug approval. But don’t feel bad if you missed the news late last week... | endpts.com... |
| 09.01.2017 | Allergan bags two new deals, takes option to buy Lysoso... | Kees Been
Allergan swooped into JP Morgan bearing news of a pair of deals, inking an exclusi... | endpts.com... |
| 03.10.2016 | MedImmune out-licenses potential medicine for inflammatory d... | MedImmune out-licenses potential medicine for inflammatory diseases to Allergan
03-10-2016
AstraZene... | cambridgen... |
| 21.09.2016 | Allergan Acquires Akarna Therapeutics, for $50M | Allergan plc., (NYSE: AGN), acquired Akarna Therapeutics Ltd., a Cambridge, UK-based biopharmaceutic... | finsmes.co... |
| 12.09.2016 | With small RetroSense deal, Allergan hoping for big win | RP is a group of congenital retinal diseases driven by mutations in the rhodopsin gene. The disease ... | medcitynew... |
| 06.09.2016 | Allergan CEO Brent Saunders takes a pricing pledge: Pred... | Brent Saunders, Allergan
Caught in the latest tempest over dramatic price hikes for old ther... | endpts.com... |
| 06.09.2016 | Allergan CEO promises to limit price hikes on drugs in a bid... | Seeking to deflect harsh criticism of the pharmaceutical industry, one chief executive officer — All... | statnews.c... |
| 27.07.2016 | Schneider Electric Accelerates Renewable Energy Transactions... | Schneider Electric today introduced the New Energy Opportunities (NEO) Network™, a collaborative onl... | pv-magazin... |
| 22.04.2016 | Allergan Acquires Topokine Therapeutics, for $85M | Allergan plc (NYSE: AGN), a Dublin, Ireland-based pharmaceutical company, acquired Topokine Therapeu... | finsmes.co... |
| 06.04.2016 | Pfizer backs out of $160B Allergan deal; White House scores ... | The Treasury Department said Monday that new rules would limit companies’ ability to participate in ... | medcitynew... |
| 01.02.2016 | Awaiting approval for merger, Allergan touts economic impact... | In an unusual move, Allergan has touted a study detailing its many contributions to the economy in W... | statnews.c... |
| 07.01.2016 | Allergan Acquires Anterios for $90M | Allergan plc (NYSE: AGN), a Dublin, Ireland-based global pharmaceutical company, acquired Anterios, ... | finsmes.co... |
| 01.12.2015 | Allergan and New York settle suit over Alzheimer’s drug swit... | Allergan and New York State have settled a heated antitrust lawsuit that accused the drug maker of s... | statnews.c... |
| 07.09.2015 | Allergan Buys AqueSys for $300M | Allergan plc (NYSE: AGN), a Dublin, Ireland-based global pharmaceutical company, is to acquire AqueS... | finsmes.co... |
| 27.07.2015 | Following Its $560M Acquisition, NU Drug Startup Naurex Laun... | This weekend Naurex, an Evanston-based biopharma company that creates depression-treating drugs, was... | bizjournal... |
| 06.07.2015 | Allergan to Acquire Oculeve for $125M | Allergan plc (NYSE: AGN), a Dublin, Ireland-based global pharmaceutical company, is to acquire Ocule... | finsmes.co... |
| 18.06.2015 | 3 billionaire tech industry leaders will build robots, Aller... | “As we enter the data technology era, robotics will become a critical field that catalyzes technolog... | medcitynew... |
| 07.01.2014 | Incubator with six venture-backed spinouts seeks 2014 exit, ... | The six venture-backed spinouts include:
Baronova, a startup trying for weight loss devices that are... | medcitynew... |
| 09.07.2013 | CEO Insight: Allergan’s David Pyott on demonstrating value | By David Pyott
At the recent BIO Convention, Ernst & Young issued its annual biotechnology indus... | massdevice... |
| 02.07.2013 | CEO Insights: What does “Value” mean in healthcare? | By David Pyott
Most companies that provide a good or service widely profess “our customers are our h... | massdevice... |
| 10.06.2013 | CEO Insight: Allergan’s David Pyott on the federal Sunshine ... | By David Pyott
One of the realities of federal laws in the United States is that the passage of legi... | massdevice... |
| 24.10.2012 | Dermatology therapeutics firm is born with $21M series A rou... | Stephen Tullman, who was an executive chairman with Vicept, will be the chairman of Aclaris’ board. ... | medcitynew... |
| 04.09.2012 | Botox maker Allergan expands R&D in U.S., defies outsour... | The anti-aging market is set to grow to $274.5 billion by 2013, according to data attributed to BCC ... | medcitynew... |
| 21.08.2012 | Molecular Partners signs Billion Dollar Contract with Allerg... | | startuptic... |
| 16.08.2011 | Allergan veteran to lead TearScience European business | Between 20 million and 30 million Americans suffer from dry eyes, according to market research from ... | medcitynew... |
| 30.03.2011 | Dry eye drug from Inspire gets patent extension in Japan | Diquafosol tetrasodium, marketed as Diquas, was launched in December by Japan-based drug partner San... | medcitynew... |
| 17.02.2011 | Allergan wins FDA approval for broader use of weight loss de... | Allergan Inc.’s (NYSE:AGN) Lap-Band is now approved for use in less-obese patients.
The Food & D... | massdevice... |
| 26.01.2011 | Allergan slides on breast implant-cancer link | Shares of Allergan Inc. (NYSE:AGN) stock were down nearly 2 percent after a Food & Drug Administ... | massdevice... |
| 15.09.2010 | Ohio to get $4M from national settlements with two drugmaker... | “As a result of these improper marketing campaigns, the Medicaid program in Ohio was paying for drug... | medcitynew... |
| 22.01.2010 | Health care tops VC funding in ’09: MedCity Morning Read, Ja... | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Healt... | medcitynew... |
| 19.01.2010 | Allergan and Covidien renew Lap-Band co-promotion agreement | Covidien (NYSE:COV) and Allergan Inc. (NYSE:AGN) extended a deal that has Covidien promoting Allerga... | massdevice... |
| 23.10.2008 | BAROnova pulls in funds for weight-loss tech | Medical technology company BAROnova announced today that it brought in $7.5 million in a second roun... | venturebea... |
| 20.09.2007 | Life sciences briefing: Thursday, Sept. 20, 2007 | Featured companies: Allergan, Athenahealth, Atria Genetics, Celera, Esprit Pharmaceuticals, Vida Dia... | venturebea... |
| - | How open science and external innovation are transforming dr... | For nearly 70 years, the traditional drug development model has been one in which large pharmaceutic... | statnews.c... |
| - | Clinical trials of Allergan’s antidepressant rapastinel fail... | An investment by Allergan of more than half a billion dollars appears not to have paid off.
The Dubl... | medcitynew... |
| - | Eye disease entrepreneurs raise $16M for Azura Ophthalmics | Close-up of woman’s blue eye. High Technologies in the futuristic. : contact lens
Azura Ophthalmics,... | medcitynew... |
| - | Dry eye drug from Inspire gets patent extension in Japan | Two dry eye therapy patents owned by Inspire Pharmaceuticals (NASDAQ:ISPH) have received extensions ... | medcitynew... |
| - | Pfizer backs out of $160B Allergan deal; White House scores ... | We can chalk this up as a huge win for the Obama administration: Pfizer’s backed out of that histori... | medcitynew... |
| - | Health care tops VC funding in ’09: MedCity Morning Read, Ja... | Image via Wikipedia
Highlights of the important and the interesting from the world of health care:
H... | medcitynew... |
| - | Ohio to get $4M from national settlements with two drugmaker... | Ohio will receive a $4 million cut of national legal settlements with two drugmakers that allegedly ... | medcitynew... |
| - | 3 billionaire tech industry leaders will build robots, Aller... | TOP STORIES
A trio of Asian tech industry giants will work together to bring Pepper, the humanoid ro... | medcitynew... |
| - | Dermatology therapeutics firm is born with $21M series A rou... | One year after Botox maker Allergan (NYSE:AGN) acquired his dermatology company, Vicept Therapeutics... | medcitynew... |
| - | With small RetroSense deal, Allergan hoping for big win | Allergan’s recent deal for gene therapy company RetroSense Therapeutics, based in Ann Arbor, Michiga... | medcitynew... |
| - | On the cusp of a new era for migraineurs | We’ve seen major biopharmaceutical discoveries in areas like oncology, cardiovascular disease, diabe... | statnews.c... |
| - | Allergan veteran to lead TearScience European business | Medical device company TearScience has hired a former Allergan (NYSE:AGN) executive to spearhead Eur... | medcitynew... |
| - | Incubator with six venture-backed spinouts seeks 2014 exit, ... | TheraNova is a San Francisco-based sandbox incubator and capital technology developer for medical de... | medcitynew... |
| - | Botox maker Allergan expands R&D in U.S., defies outsour... | The trend of outsourcing research and development work that spurred massive layoffs by pharmaceutica... | medcitynew... |
